Henrik Berg Rasmussen

Medicine & Life Sciences

1. Schizophrenia 100%
2. Carboxylesterase 58%
3. Genes 56%
4. Cytochrome P-450 CYP2D6 42%
5. Methylphenidate 38%
6. Single Nucleotide Polymorphism 35%
7. Genome-Wide Association Study 31%
8. Alleles 28%
9. Cytochrome P-450 CYP2C19 25%
10. Genotype 23%
11. Mental Disorders 19%
12. Angiotensin-Converting Enzyme Inhibitors 19%
13. Pharmaceutical Preparations 18%
14. Pharmacokinetics 17%
15. Attention Deficit Disorder with Hyperactivity 16%
16. Antipsychotic Agents 16%
17. ritalinic acid 15%
18. Dopamine beta-Hydroxylase 15%
19. Genetic Variation 15%
20. Serotonin Plasma Membrane Transport Proteins 15%
21. Bipolar Disorder 14%
22. human CES1 protein 14%
23. Genome 12%
24. Tandem Repeat Sequences 12%
25. Enzymes 11%
26. Linkage Disequilibrium 11%
27. Neuregulin-1 10%
28. Pharmacogenetics 10%
29. Pharmacogenomic Testing 10%
30. Enalapril 10%
31. Elderly 9%
32. Nucleotides 9%
33. Psychiatry 9%
34. Haplotypes 9%
35. Heart Failure 9%
36. Meta-Analysis 9%
37. Carboxylic Ester Hydrolases 8%
38. Dopamine Receptors 8%
39. Mixed Function Oxygenases 8%
40. Cytochrome P-450 Enzyme System 8%
41. Metabolomics 8%
42. Psychotic Disorders 7%
43. Genetic Pleiotropy 7%
44. Healthy Volunteers 7%
45. Alcohol Drinking 7%
46. Confidence Intervals 7%
47. Case-Control Studies 7%
48. Therapeutics 7%
49. DNA 7%
50. Exons 7%